Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-22-026687
Filing Date
2022-10-19
Accepted
2022-10-19 20:08:00
Documents
2
Period of Report
2022-10-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_166622446266833.html 3  
1 FORM 3 wf-form3_166622446266833.xml 3 2934
2 KAYE FOSTER-CHEEK - POA ex-24.htm EX-24 4660
  Complete submission text file 0001628280-22-026687.txt   8954
Mailing Address JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Business Address
Foster-Cheek Kaye I (Reporting) CIK: 0001312622 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41536 | Film No.: 221319565

Mailing Address 21 ERIE ST. CAMBRIDGE MA 02139
Business Address 21 ERIE ST. CAMBRIDGE MA 02139 617-465-0013
Prime Medicine, Inc. (Issuer) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)